Related Experiment Video
Updated: May 22, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
ELMOD2 Overexpression Predicts Adverse Outcomes and Regulates Tumor Progression in Gliomas
Rui-Chao Li1,2, Chang Liu3, Guo-Jian Wang1
1Department of Histology and Embryology, School of Basic Medicine Science, Guangxi Medical University, Nanning, 530021, China.
ELMO domain containing 2 (ELMOD2) is overexpressed in gliomas, correlating with poor prognosis and promoting tumor growth. Knocking down ELMOD2 inhibits glioma cell proliferation and invasion, identifying it as a potential therapeutic target.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Glioma is a malignant brain tumor with challenging treatment outcomes.
- ELMO domain containing 2 (ELMOD2) is a GTPase-activating protein with an unknown role in glioma tumorigenesis.
Purpose of the Study:
- To investigate the prognostic relevance and signaling function of ELMOD2 in gliomas.
- To assess ELMOD2 as a potential biomarker and therapeutic target for glioma.
Main Methods:
- Analysis of ELMOD2 expression in TCGA and CGGA databases.
- Single-cell analysis, GO, KEGG, and GSVA for functional evaluation.
- In vitro knockdown of ELMOD2 in glioma cell lines (U251, A172) to assess cellular behavior and signaling pathways.
Main Results:
- ELMOD2 is overexpressed in gliomas, associated with higher tumor grade and specific molecular subtypes.
- ELMOD2 knockdown reduced glioma cell proliferation, migration, and invasion, while increasing apoptosis.
- ELMOD2 regulates cell cycle progression and impacts p-Erk1/2 signaling.
Conclusions:
- ELMOD2 expression is positively correlated with glioma tumorigenesis and serves as an independent prognostic marker.
- ELMOD2 represents a promising biomarker and therapeutic target for glioma treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

